Additional Info: Values obtained with different assay methods or kits can not be used interchangeably. CA 27.29 is not to be used as a diagnostic procedure without confirmation of the diagnosis by another established product or procedure.
CA 27.29 is useful to monitor the response to treatment and, if elevated, suggests recurrence in women with stage II or III breast cancer.
1 mL serum (minimum volume 0.5 mL)
Serum Separator Tube (SST®)
Days Set Up: Monday through Friday